Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines

Abstract

Objective:

To determine (a) the proportion of asymptomatic infants born at 35 weeks gestation evaluated for early-onset sepsis (EOS) and exposed to postnatal antibiotics; (b) reasons for and outcomes of the evaluations, and (c) anticipated changes when applying the Centers for Disease Control and Prevention (CDC) 2010 guidelines to this study population.

Study Design:

Retrospective cohort study of infants born at 35 weeks gestation in 2008–2009 in a large maternity center.

Result:

Out of the 7226 infants that met the study criteria: 1062 (14.7%) were evaluated for EOS and half of those evaluated, received empiric antibiotics. 70.4% of evaluations were performed owing to maternal intrapartum fever, but 23% were prompted by inadequate Group B Streptococcus (GBS) prophylaxis alone. Three cases of blood culture-proven infection were identified.

Conclusion:

Improved approaches are needed to identify asymptomatic infants who are at risk for EOS to decrease unnecessary evaluations and antibiotic exposure. Transition to the 2010 CDC GBS guidelines may eliminate a quarter of EOS evaluations among these infants.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Centers for Disease Control and Prevention (CDC). Early-onset and late-onset neonatal group B streptococcal disease—United States, 1996–2004. MMWR Morb Mortal Wkly Rep 2005; 54: 1205–1208.

    Google Scholar 

  2. Centers for Disease Control and Prevention (CDC). Trends in perinatal group B streptococcal disease - United States, 2000–2006. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2009; 58: 109–112.

    Google Scholar 

  3. Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005–2008. Pediatr Infect Dis J 2011; 30: 937–941.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Puopolo KM, Eichenwald EC . No change in the incidence of ampicillin-resistant, neonatal, early-onset sepsis over 18 years. Pediatrics 2010; 125: e1031–e1038.

    Article  PubMed  Google Scholar 

  5. Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for disease control and prevention. MMWR Recomm Rep 1996; 45: 1–24.

    Google Scholar 

  6. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A . Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51: 1–22.

    PubMed  Google Scholar 

  7. Verani JR, McGee L, Schrag SJ . Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep 2010; 59: 1–36.

    PubMed  Google Scholar 

  8. Benirschke K . Routes and types of infection in the fetus and the newborn. Am J Dis Child 1960; 99: 714–721.

    CAS  Google Scholar 

  9. Alexander JM, McIntire DM, Leveno KJ . Chorioamnionitis and the prognosis for term infants. Obstet Gynecol 1999; 94: 274–278.

    CAS  PubMed  Google Scholar 

  10. Escobar GJ, Li DK, Armstrong MA, Gardner MN, Folck BF, Verdi JE et al. Neonatal sepsis workups in infants >/=2000 grams at birth: a population-based study. Pediatrics 2000; 106: 256–263.

    Article  CAS  PubMed  Google Scholar 

  11. Benitz WE, Gould JB, Druzin ML . Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics 1999; 103: e77.

    Article  CAS  PubMed  Google Scholar 

  12. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009; 360: 2626–2636.

    Article  CAS  PubMed  Google Scholar 

  13. Cotten CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin Jr DK . The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006; 118: 717–722.

    Article  PubMed  Google Scholar 

  14. Cotten CM, Taylor S, Stoll B, Goldberg RN, Hansen NI, Sanchez PJ et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009; 123: 58–66.

    Article  PubMed  Google Scholar 

  15. Kuppala VS, Meinzen-Der J, Morrow AL, Schibler KR . Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011; 159: 720–725.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Vanaja N, Alexander VN, Northrup V, Bizzarro MJ . Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 2011; 159: 392–397.

    Article  Google Scholar 

  17. Alm B, Erdes L, Möllborg P, Pettersson R, Norvenius SG, Aberg N et al. Neonatal antibiotic treatment is a risk factor for early wheezing. Pediatrics 2008; 121: 697–702.

    Article  PubMed  Google Scholar 

  18. Goksör E, Alm B, Thengilsdottir H, Pettersson R, Åberg N, Wennergren G . Preschool wheeze - impact of early fish introduction and neonatal antibiotics. Acta Paediatr 2011; 100: 1561–1566.

    Article  PubMed  Google Scholar 

  19. Bitner-Glindzicz M, Pembrey M, Duncan A, Heron J, Ring SM, Hall A et al. Prevalence of mitochondrial 1555A-->G mutation in European children. N Engl J Med 2009; 360: 640–642.

    Article  PubMed  Google Scholar 

  20. Murgas Torrazza R, Neu J . The developing intestinal microbiome and its relationship to health and disease in the neonate. J Perinatol 2011; 31 (Suppl 1): S29–S34.

    Article  PubMed  Google Scholar 

  21. Puopolo KM, Draper D, Wi S, Newman TB, Zupancic J, Lieberman E et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors. Pediatrics 2011; 128: e1155–e1163.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Polin RA . Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics 2012; 129: 1006–1015.

    Article  PubMed  Google Scholar 

  23. Puopolo KM, Madoff LC, Eichenwald EC . Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005; 115: 1240–1246.

    Article  PubMed  Google Scholar 

  24. Boyer KM, Gotoff SP . Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum.chemoprophylaxis. N Engl J Med 1986; 314: 1665–1669.

    Article  CAS  PubMed  Google Scholar 

  25. Newman TB, Puopolo KM, Wi S, Draper D, Escobar GJ . Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010; 126: 903–909.

    Article  PubMed  Google Scholar 

  26. Van Dyke MK, Phares CR, Lynfield R, Thomas AR, Arnold KE, Craig AS et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009; 360: 2626–2636.

    Article  CAS  PubMed  Google Scholar 

  27. Lieberman E, Lang JM, Frigoletto Jr F, Richardson DK, Ringer SA, Cohen A . Epidural analgesia, intrapartum fever, and neonatal sepsis evaluation. Pediatrics 1997; 99: 415–419.

    Article  CAS  PubMed  Google Scholar 

  28. No authors listed. Massachusetts maternity data as reported by hospitals. Available at http://www.mass.gov/eohhs/docs/dhcfp/qc/archives/qc2/mat-procedures.pdf. Accessed on 1 December 2011.

Download references

Acknowledgements

We thank the Dr Ruth Tuomala and Dr Alison Cape for the obstetrical contributions to the study; the Centers for Clinical Excellence at Brigham and Women's Hospital for hospital demographic information; and Dr Stella Kourembanas, the Division of Newborn Medicine at Children's Hospital and the Scholars in Clinical Science Program for ongoing support of Dr Mukhopadhyay.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K M Puopolo.

Ethics declarations

Competing interests

The authors declare no conflict to interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mukhopadhyay, S., Eichenwald, E. & Puopolo, K. Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines. J Perinatol 33, 198–205 (2013). https://doi.org/10.1038/jp.2012.96

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2012.96

Keywords

This article is cited by

Search

Quick links